University of Texas M. D. Anderson Cancer Center HOUSTON ― The University of Texas MD Anderson Cancer Center 's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include promising results from combining immunotherapy with radiation for non-small cell lung cancer (NSCLC), a novel combination therapy for secondary and treatment-resistant blood cancers, understanding the prognostic value of splicing factor gene mutations in AML, an approach to overcoming treatment resistance in HR-positive/HER2-negative metastatic breast cancer, a new treatment strategy for metastatic appendix cancer, improved survival outcomes for young adults with multiple myeloma, a preventive treatment to lessen toxicities from chimeric antigen receptor (CAR) T cell therapy, and the use of artificial intelligence to improve prognostic models for patients with cancer.

https://www.miragenews.com/md-anderson-research-highlights-july-19-2023-1050057/

#miragenews